For research use only. Not for therapeutic Use.
CYP1B1-IN-4（Cat No.:I042285）is a selective inhibitor of the cytochrome P450 enzyme CYP1B1, which is involved in the metabolism of various endogenous and exogenous compounds, including procarcinogens and estrogens. CYP1B1 is highly expressed in certain cancer cells, particularly in breast, prostate, and lung cancers. Inhibition of CYP1B1 by compounds like CYP1B1-IN-4 can potentially reduce tumor growth by blocking the activation of carcinogenic substances and modulating estrogen signaling. This makes CYP1B1-IN-4 a promising candidate for cancer therapy, especially in tumors that overexpress CYP1B1 and rely on its enzymatic activity for growth and survival.
| Catalog Number | I042285 |
| CAS Number | 2685779-55-7 |
| Synonyms | 4-[2-(2,4-dimethoxyphenyl)-1,3-thiazol-4-yl]benzonitrile |
| Molecular Formula | C18H14N2O2S |
| Purity | ≥95% |
| IUPAC Name | 4-[2-(2,4-dimethoxyphenyl)-1,3-thiazol-4-yl]benzonitrile |
| InChI | InChI=1S/C18H14N2O2S/c1-21-14-7-8-15(17(9-14)22-2)18-20-16(11-23-18)13-5-3-12(10-19)4-6-13/h3-9,11H,1-2H3 |
| InChIKey | SCCIDJLIDOUTOW-UHFFFAOYSA-N |
| SMILES | COC1=CC(=C(C=C1)C2=NC(=CS2)C3=CC=C(C=C3)C#N)OC |
